Abstract PO-220: Associations of timing of Medicaid enrollment with stage at diagnosis, treatment delays, and mortality in women with breast cancer

2022 ◽  
Author(s):  
Evaline Xie ◽  
Graham A. Colditz ◽  
Min Lian ◽  
Tracy Greever-Rice ◽  
Chester Schmaltz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stage At Diagnosis ◽  
Treatment Delays ◽  
Medicaid Enrollment

Breast Cancer Stage at Diagnosis in Relation to Duration of Medicaid Enrollment

Medical Care ◽  
2001 ◽  
Vol 39 (11) ◽  
pp. 1224-1233 ◽  
Author(s):  
Carin I. Perkins ◽  
William E. Wright ◽  
Mark Allen ◽  
Steven J. Samuels ◽  
Patrick S. Romano
Keyword(s):  
Breast Cancer ◽  
Cancer Stage ◽  
Stage At Diagnosis ◽  
Medicaid Enrollment

scholarly journals Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era

ESMO Open ◽  
2021 ◽  
Vol 6 (2) ◽  
pp. 100055
Author(s):  
A. Toss ◽  
C. Isca ◽  
M. Venturelli ◽  
C. Nasso ◽  
G. Ficarra ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Mammographic Screening ◽  
Cancer Stage ◽  
Stage At Diagnosis

scholarly journals Socio-Economic Position, Cancer Incidence and Stage at Diagnosis: A Nationwide Cohort Study in Belgium

Cancers ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 933
Author(s):  
Michael Rosskamp ◽  
Julie Verbeeck ◽  
Sylvie Gadeyne ◽  
Freija Verdoodt ◽  
Harlinde De Schutter
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Cohort Study ◽  
Cancer Incidence ◽  
Regression Models ◽  
Female Breast Cancer ◽  
Stage At Diagnosis ◽  
Female Breast ◽  
Economic Parameters ◽  
Economic Position

Background: Socio-economic position is associated with cancer incidence, but the direction and magnitude of this relationship differs across cancer types, geographical regions, and socio-economic parameters. In this nationwide cohort study, we evaluated the association between different individual-level socio-economic and -demographic factors, cancer incidence, and stage at diagnosis in Belgium. Methods: The 2001 census was linked to the nationwide Belgian Cancer Registry for cancer diagnoses between 2004 and 2013. Socio-economic parameters included education level, household composition, and housing conditions. Incidence rate ratios were assessed through Poisson regression models. Stage-specific analyses were conducted through logistic regression models. Results: Deprived groups showed higher risks for lung cancer and head and neck cancers, whereas an inverse relation was observed for malignant melanoma and female breast cancer. Typically, associations were more pronounced in men than in women. A lower socio-economic position was associated with reduced chances of being diagnosed with known or early stage at diagnosis; the strongest disparities were found for male lung cancer and female breast cancer. Conclusions: This study identified population groups at increased risk of cancer and unknown or advanced stage at diagnosis in Belgium. Further investigation is needed to build a comprehensive picture of socio-economic inequality in cancer incidence.

scholarly journals Age-related socio-economic and geographic disparities in breast cancer stage at diagnosis: a population-based study

2015 ◽  
Vol 25 (6) ◽  
pp. 966-972 ◽  
Author(s):  
Pegdwende O. Dialla ◽  
Patrick Arveux ◽  
Samiratou Ouedraogo ◽  
Carole Pornet ◽  
Aurélie Bertaut ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Population Based ◽  
Cancer Stage ◽  
Stage At Diagnosis ◽  
Population Based Study ◽  
Geographic Disparities ◽  
Age Related

Distant metastases after diagnosis: Racial disparities in breast cancer outcomes.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. 1084-1084
Author(s):  
Julia Blanter ◽  
Ilana Ramer ◽  
Justina Ray ◽  
Emily J. Gallagher ◽  
Nina A. Bickell ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Multivariate Analysis ◽  
Black Women ◽  
Racial Disparities ◽  
Late Stage ◽  
White Women ◽  
Univariate Analysis ◽  
Distant Metastases ◽  
Stage At Diagnosis

1084 Background: Black women diagnosed with breast cancer are more likely to have a poor prognosis, regardless of breast cancer subtype. Despite having a lower incidence rate of breast cancer when compared to white women, black women have the highest breast cancer death rate of all racial and ethnic groups, a characteristic often attributed to late stage at diagnosis. Distant metastases are considered the leading cause of death from breast cancer. We performed a follow up study of women with breast cancer in the Mount Sinai Health System (MSHS) to determine differences in distant metastases rates among black versus white women. Methods: Women were initially recruited as part of an NIH funded cross-sectional study from 2013-2020 to examine the link between insulin resistance (IR) and breast cancer prognosis. Women self-identified as black or white race. Data was collected via retrospective analysis of electronic medical records (EMR) between September 2020-January 2021. Distant metastases at diagnosis was defined as evidence of metastases in a secondary organ (not lymph node). Stage at diagnosis was recorded for all patients. Distant metastases after diagnosis was defined as evidence of metastases at any time after initiation of treatment. Univariate analysis was performed using Fisher’s exact test, multivariate analysis was performed by binary logistic regression, and results expressed as odds ratio (OR) and 95% confidence interval (CI). A p value <0.05 was considered statistically significant. Results: We identified 441 women enrolled in the IR study within the MSHS (340 white women, 101 black women). Median follow up time for all women was 2.95 years (median = 3.12 years for white and 2.51 years for black women (p=0.017)). Among these patients, 11 developed distant metastases after diagnosis: 4 (1.2%) white and 7 (6.9%) black (p=0.004). Multivariate analysis adjusting for age, race and stage at diagnosis revealed that black women were more likely to have distant metastasis (OR 5.8, CI 1.3-25.2), as were younger women (OR for age (years) 0.9, CI 0.9-1.0), and those with more advanced stage at diagnosis. Conclusions: Black women demonstrated a far higher percentage of distant metastases after diagnosis even when accounting for age and stage. These findings suggest that racial disparities still exist in the development of distant metastases, independent from a late-stage diagnosis. The source of existing disparities needs to be further understood and may be found in surveillance, treatment differences, or follow up.

Changing Patterns of Breast Cancer Stage at Diagnosis in Southern Italy: Hospital Data as Indicators of Progressive Changes

2000 ◽  
Vol 30 (2) ◽  
pp. 174-177 ◽  
Author(s):  
Maurizio Montella ◽  
Marina Buonanno ◽  
Edoardo Biondi ◽  
Anna Crispo ◽  
Mariarosaria De Marco ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Southern Italy ◽  
Cancer Stage ◽  
Stage At Diagnosis ◽  
Hospital Data ◽  
Changing Patterns

Treatment delays from transfers of care and their impact on breast cancer quality measures

2018 ◽  
Vol 173 (3) ◽  
pp. 603-617 ◽  
Author(s):  
Richard J. Bleicher ◽  
Cecilia Chang ◽  
Chihsiung E. Wang ◽  
Lori J. Goldstein ◽  
Cary S. Kaufmann ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Measures ◽  
Treatment Delays ◽  
Transfers Of Care

Body Mass Index Influences Palpability but not Stage of Breast Cancer at Diagnosis

2007 ◽  
Vol 73 (6) ◽  
pp. 555-560 ◽  
Author(s):  
Anees B. Chagpar ◽  
Kelly M. Mcmasters ◽  
Jeremy Saul ◽  
Jacob Nurko ◽  
Robert C.G. Martin ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Body Mass Index ◽  
Estrogen Receptor ◽  
Body Mass ◽  
North American ◽  
Tumor Size ◽  
Estrogen Receptor Status ◽  
Stage At Diagnosis ◽  
Histologic Subtype ◽  
The North

Body mass index (BMI) is associated with breast cancer risk, but its relationship with stage at diagnosis is unclear. BMI was calculated for patients in the North American Fareston and Tamoxifen Adjuvant trial, and was correlated with clinicopathologic factors, including stage at diagnosis. One thousand eight hundred fourteen patients were enrolled in the North American Fareston and Tamoxifen Adjuvant study; height and weight were recorded in 1451 (80%) of them. The median BMI was 27.1 kg/m2 (range, 14.7–60.7). The median patient age was 68 years (range, 42–100); median tumor size was 1.3 cm (range, 0.1–14 cm). One thousand seven hundred ninety-three (99.0%) patients were estrogen receptor positive, and 1519 (84.7%) were progesterone receptor positive. There was no significant relationship between BMI (as a continuous variable) and nodal status ( P = 0.469), tumor size ( P = 0.497), American Joint Committee on Cancer stage ( P = 0.167), grade ( P = 0.675), histologic subtype ( P = 0.179), or estrogen receptor status ( P = 0.962). Patients with palpable tumors, however, had a lower BMI than those with nonpalpable tumors (median 26.4 kg/m2 vs 27.5 kg/m2, P < 0.001). Similar results were found when BMI was classified as a categorical variable (<25 vs 25–29.9 vs ≥30). Increased BMI does not lead to a worse stage at presentation. Obese patients, however, tend to have nonpalpable tumors. Mammography in this population is especially important.

Sign in / Sign up

Export Citation Format

Share Document